EBR Systems, Inc. (EBRCZ) stock
Close on Oct 19, 2026Market cap $9.07MP/E –Yield –
EBR Systems, Inc. reported revenue of $8.42M for the twelve months to Sep 30, 2026. Free cash flow was -$77.39M. At the latest close the market valued the company at $9.07M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $9.07M
- P/E ratio
- –
- Price to sales
- 1.08
- Price to book
- 0.12
- Dividend yield
- –
- Free cash flow yield
- -853.33%
Fundamentals
- Revenue
- $8.42M
- Net income
- -$65.22M
- EPS, diluted
- -$1.25
- Free cash flow
- -$77.39M
- Book value per share
- $0.97
- Diluted shares
- 79M
Trading
- Previous close
- $0.11
- Open
- $0.11
- Day's range
- $0.11 – $0.11
- Volume
- 0
- Average volume (20 days)
- 11,319
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | EBRCZ | S&P 500 | Difference | EBRCZ per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -47.8% | +0.6% | −48.5 pts | ||
| 3 months | -59.0% | +3.4% | −62.4 pts | ||
| Year to date | -90.4% | +13.3% | −103.6 pts | ||
| 1 year | -87.9% | +16.6% | −104.5 pts | ||
| 3 years | -79.1% | +86.4% | −165.4 pts | -40.6% | +23.1% |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases EBR Systems filed with the SEC as exhibits to Form 8-K or 6-K
About EBR Systems
Surgical & Medical Instruments & Apparatus
EBR Systems, Inc. develops implantable cardiac pacing devices designed to stimulate heart tissue without conventional leads. The company’s core offering is the WiSE CRT System, an implantable system providing cardiac resynchronization therapy for heart rhythm disorders. This technology converts ultrasound energy into electrical pulses to stimulate the left ventricle in conjunction with a co-implanted right ventricular pacing device. The product targets adult patients requiring cardiac resynchronization who cannot use standard lead systems due to previous failed implantations or high complication risks during upgrades.
Company profile, executives and historyEBR Systems stock: common questions
What is EBR Systems's stock price?
EBRCZ closed at $0.11 on Oct 19, 2026, up 0.00% on the day.
What is EBR Systems's market cap?
EBR Systems was worth $9.07M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is EBRCZ's P/E ratio?
EBR Systems lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.25), so it has no meaningful P/E ratio.
How much revenue does EBR Systems make?
EBR Systems reported revenue of $8.42M for the twelve months to Sep 30, 2026.
Does EBR Systems pay a dividend?
No. EBR Systems has not paid a cash dividend over the last twelve months.
How has EBRCZ stock performed over the past year?
Including dividends, EBRCZ returned -87.9% over the past year, against +16.6% for the S&P 500.
Who are EBR Systems's competitors?
Companies most similar to EBR Systems by business, industry and size include PMI, NMTC, BTCY, CVRX, NSPR.
See a number that looks wrong?